Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice

European Neuropsychopharmacology

Volumn 10, Issue 3, 2000, Pages 159-164

  Simon V M ^a   Parra, A ^a   Minarro J ^a   Arenas, M C ^a   Vinader Caerols, C ^a   Aguilar, M A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Chlorpromazine; Clozapine; Haloperidol; Motor activity; Raclopride; Sulpiride

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; RACLOPRIDE; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; FEMALE; LOCOMOTION; MALE; MOTOR ACTIVITY; MOTOR RETARDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0034000298     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(00)00070-5     Document Type: Article

References (33)

1. Acquas E., Carboni E., Leone P., Di Chiara G. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology. 99:1989;151-155.
2. Aguilar M.A., Miñarro J., Pérez-Iranzo N., Simón V.M. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol. Biochem. Behav. 47:1994;756-763.
3. Aguilar M.A., Rodríguez-Arias M., Miñarro J. Efectos del haloperidol y del sulpiride sobre la conducta motora en ratones macho. Psicológica. 18:1995;429-439.
4. Ahlenius S. Pharmacological evaluation of new antipsychotic drugs. Willner P. Behavioural Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. 1991;Cambridge University Press, Cambridge.
5. Arenas M.C., Parra A., Simón V.M. Gender differences in escape-avoidance behavior of mice after haloperidol administration. Pharmacol. Biochem. Behav. 44:1993;233-236.
6. Arenas M.C., Parra A., Simón V.M. Gender differences in the effects of haloperidol on avoidance conditioning in mice. Pharmacol. Biochem. Behav. 51:1995;601-609.
7. Arnt J. Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation of dopamine receptor blockade. Acta Pharmacol. Toxicol. 51:1982;321-329.
8. Ayd F.J. Jr. A survey of drug-induced extrapyramidal reactions. J. Am. Med. Assoc. 25:1961;102-108.
9. Beninger R.J. The role of dopamine in locomotor activity and learning. Brain Res. Rev. 6:1983;173-196.
10. Beninger R.J. Dissociating the effects of altered dopaminergic function on performance and learning. Brain Res. Bull. 23:1989;365-371.
11. Cabib S., Castellano C., Cestari V., Filibeck U., Puglisi-Allegra S. D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse. Psychopharmacology. 105:1991;335-339.
12. Chausmer L.A., Ettenberg A. A role for D2, but not D1, dopamine receptors in the response-reinstating effects of food reinforcement. Pharmacol. Biochem. Behav. 57:1997;681-685.
13. Ereshefsky L., Watanabe M.D., Tran-Johnson T.K. Clozapine: an atypical antipsychotic agent. Clin. Pharm. 8:1989;691-709.
14. Fujiwara H. Comparative studies of sulpiride and classical neuroleptics on induction of catalepsy, locomotor activity, and brain dopamine metabolism in mice. Pharmacol. Biochem. Behav. 41:1992;301-308.
15. Gleason S.D., Shannon H.E. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology. 129:1997;79-84.
16. Horvitz J.C., Ettenberg A. Haloperidol blocks the response-reinstating effects of food reward: A methodology for separating neuroleptic effects on reinforcement and motor processes. Pharmacol. Biochem. Behav. 31:1989;861-865.
17. Laborit H. Un nouveau stabilisateur végétatif (Le 4560 RP). La presse Medicale. 60:1952;206-208.
18. Lapin I.P., Yuwiler A. Modulation of the inhibitory effect of phenylethylamine on spontaneous motor activity in mice by CPP-(+)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid. Pharmacol. Biochem. Behav. 56:1997;199-204.
19. Meil W.M., Schechter M.D. Olanzapine attenuates the reinforcing effects of cocaine. Eur. J. Pharmacol. 340:1997;17-26.
20. 4 receptor selective antagonist. J. Pharmacol. Exp. Ther. 279:1996;1392-1403.
21. Monleón S., Parra A. The higher the dose, the greater the sex differences in escape-avoidance response in mice after acute administration of haloperidol. Pharmacol. Biochem. Behav. 60:1998;279-284.
22. Monleón S., Vinader-Caerols C., Parra A. Sex differences in escape-avoidance response in mice after acute administration of raclopride, clozapine and SCH 23390. Pharmacol. Biochem. Behav. 60:1998;489-497.
23. Nakajima S., Liu X., Lau C.L. Synergistic interaction of D1 and D2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation. Behav. Neurosci. 107:1993;161-165.
24. Niemegeers C.J., Janssen P.A. A systematic study of the pharmacological activities of dopamine antagonists. Life Sci. 24:1979;2201-2216.
25. Niemegeers C.J., Verbruggen F.J., Janssen P.A. The influence of various neuroleptic drugs on shock avoidance responding in rats. I. Nondiscriminated Sidman avoidance procedure. Psychopharmacologia. 16:1969;161-174.
26. Ögren S.O. The behavioural pharmacology of typical and atypical antipsychotic drugs. Antipsychotics. 120:1996;225-266.
27. Ögren S.O., Archer T. Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blockade profile. Psychopharmacology. 114:1994;383-391.
28. Pruitt D.L., Bolanos C.A., McDougall S.A. Effects of dopamine D1 and D2 receptor antagonists on cocaine induced place preference conditioning in preweanling rats. Eur. J. Pharmacol. 283:1995;125-131.
29. Redolat R., Brain P.F., Simón V.M. Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity. Neuropharmacology. 30:1991;41-46.
30. Roberts D.C.S., Ranaldi R. Effect of dopaminergic drugs on cocaine reinforcement. Clin. Neuropharmacol. 18:(1):1995;s24-s95.
31. Salamone J.D., Cousins M.S., Buche S. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav. Brain Res. 65:1994;221-229.
32. Tang A.H., Franklin S.R., Himes C.S., Smith M.W., Tenbrink R.E. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties. J. Pharmacol. Exp. Ther. 281:1997;440-447.
33. Wise R.A. Neuroleptics and operant behaviour, the anhedonia hypothesis. Behav. Brain Sci. 5:1983;39-87.